Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Journal of Insurance Medicine (New York, N.Y.)|October 19, 2007
Mortality in co-morbidity (I)--Analysis of the results in the Multiple Medical impairment Study for impairments with elevated blood pressure as the second or co-morbid impairmentRichard B Singer, Anthony F MilanoJournal of Insurance Medicine (New York, N.Y.)|February 7, 2008
Mortality in co-morbidity (II)--excess death rates derived from a follow-up study on 10,025 subjects divided into 4 groups with or without depression and diabetes mellitusAnthony F Milano, Richard B SingerJournal of Insurance Medicine (New York, N.Y.)|March 1, 2018
The Cancer Mortality Risk Project - Cancer Mortality Risks by Anatomic Site: Part 1 - Introductory Overview; Part II - Carcinoma of the Colon: 20-Year Mortality Follow-up Derived from 1973-2013 (NCI) SEER*Stat Survival DatabaseAnthony F Milano, Richard B SingerJournal of Insurance Medicine (New York, N.Y.)|January 6, 2009
Comparative mortality in HIV-infected patients in Denmark, 1995-2005Richard B Singer, Anthony F MilanoJournal of Insurance Medicine (New York, N.Y.)|September 8, 2018
Thyroid Cancer: 20-Year Comparative Mortality and Survival Analysis of Six Thyroid Cancer Histologic Subtypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration (SEER*Stat 8.3.2) A Systematic Review of 145,457 Cases for Diagnosis Years 1993-2013Anthony F MilanoJournal of Insurance Medicine (New York, N.Y.)|September 19, 2023
Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6)Anthony F MilanoJournal of Insurance Medicine (New York, N.Y.)|January 23, 2019
Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4)Anthony F MilanoJournal of Insurance Medicine (New York, N.Y.)|November 15, 2022
Cancers of the Oral Cavity and Pharynx: 20-Year Comparative Survival and Mortality Analysis by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 218,066 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.5)Anthony F MilanoJournal of Insurance Medicine (New York, N.Y.)|February 15, 2024
Breast Cancer: 20-Year Comparative Mortality and Survival Analysis by Age, Sex, Race/Ethnicity, Stage, Grade, Disease Duration, Selected ICD-O-3 Oncophenotypes, and Cohort Entry Time-PeriodAnthony F MilanoJournal of Insurance Medicine (New York, N.Y.)|January 20, 2022
Cancer of the Liver, Intrahepatic Bile Ducts, Gallbladder, Exocrine and Neuroendocrine Pancreas: 20-Year Comparative Survival and Mortality Analysis by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes A Systematic Review of 367,420 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4)Anthony F MilanoPageof 4